Related by context. All words. (Click for frequent words.) 66 mediated dilation 64 PSA nadir 64 LV ejection fraction 64 Serum creatinine 64 detrusor 63 protein excretion 63 brachial artery flow 63 urine albumin 63 peak VO2 63 Creatinine 62 expiratory flow 62 pulmonary artery pressure 62 aspartate aminotransferase 62 microvessel density 62 serum bilirubin 62 serum bicarbonate 61 mmHg diastolic 61 serum cortisol 61 serum prostate 61 pmol L 61 methacholine challenge 61 Secondary endpoints included 61 tissue oxygenation 61 systemic hypotension 61 mL sec 61 HOMA IR 61 expiratory 61 ml min 61 urodynamic 61 hemoglobin hematocrit 61 concentration Cmax 60 Score IPSS 60 intact parathyroid hormone 60 μg liter 60 proBNP 60 SGOT 60 SpO 2 60 CK MB 60 mL/min/#.# m 2 60 Secondary endpoints include 60 neutrophil count 60 radiotherapy RT 60 salmeterol fluticasone propionate 60 International Prostate Symptom 60 pulmonary capillary wedge 60 SGPT 60 triiodothyronine 60 dyspnea shortness 60 β blocker 59 #ng/ml 59 euthyroid 59 pT3 59 mL kg 59 AUC0 59 paraprotein 59 prospectively stratified 59 AST ALT 59 preoperative PSA 59 creatine kinase MB 59 aspartate aminotransferase AST 59 partial thromboplastin 59 Visual Analog Scale 59 plasma cortisol 59 hemodilution 59 serum lactate 59 creatinine ratio 59 transcranial Doppler ultrasound 59 vasopressor 59 salivary flow 59 certolizumab 59 atrioventricular block 59 glomerular filtration 59 immunoreactive 59 TURBT 59 6MWD 59 pulsatility index 59 neutrophil counts 59 specific antigen PSA 59 kVp 59 glycosylated hemoglobin HbA1c 59 nadolol 59 #OHD 59 calculated creatinine clearance 59 inotropic 59 alanine transaminase 59 QTcF 59 hemoglobin Hb 59 Hematocrit 59 P = .# 58 fractional shortening 58 hematological parameters 58 ventricular ejection fraction 58 SCr 58 #ug [002] 58 DAS# remission 58 inspiratory 58 nmol 58 serum urate 58 LANTUS R 58 mH 58 intraocular pressure IOP 58 ALT AST 58 μmol L 58 SGRQ 58 tracer uptake 58 serum sodium levels 58 CIN2 + 58 pulmonary vascular 58 mAs 58 hemodynamic parameters 58 diameter stenosis 58 albumin excretion rate 58 undetectable HBV DNA 58 CI -#.# 58 afterload 58 N telopeptide 58 pleural fluid 58 #mmHg [001] 58 alanine aminotransferase 58 Quiescent current 58 WOMAC pain 58 bronchoalveolar lavage 58 IELT 58 sensitivity specificity 58 binary restenosis 58 intravascular hemolysis 58 endometrial thickness 58 nicardipine 58 lactate dehydrogenase LDH 58 lactate dehydrogenase 58 rFSH 58 systolic velocity 58 foveal thickness 58 intima media thickness 58 erythrocyte sedimentation rate 58 % Confidence Interval 58 platelet aggregation IPA 58 colorectal adenoma 58 mU liter 57 HBeAg seroconversion 57 pretreatment baseline 57 abacavir lamivudine 57 alanine aminotransferase ALT 57 4mg/kg 57 oxyhemoglobin 57 fructosamine 57 uL 57 OGTT 57 dysuria 57 #.#ng/ml 57 symptomatic intracranial hemorrhage 57 ropivacaine 57 eNO 57 peritumoral 57 transaminases 57 MBq 57 #mg/kg [001] 57 serum PSA 57 % CI #.#-#.# [003] 57 -#.# log# copies mL 57 IU ml 57 glomerular filtration rate 57 budesonide pMDI 57 tumor perfusion 57 TIMP 1 57 interstitial fluid 57 SpO2 57 reactive hyperemia 57 troponin T 57 μg mL 57 morphometric vertebral fractures 57 exhaled nitric oxide 57 mcg BID 57 Cardiac Troponin 57 SUVmax 57 uM 57 bioavailable testosterone 57 serum HBV DNA 57 leukocyte count 57 #.#/#.# mmHg [001] 57 Cmax 57 â ‰ ¥ 57 serum ferritin 57 lymphocytosis 57 creatine kinase 57 natriuresis 57 hemodynamic variables 57 creatine kinase CK 57 crossclamp 57 timepoints 57 serum phosphate levels 57 FDG uptake 57 bronchial hyperresponsiveness 57 albumin excretion 57 Target Lesion Revascularization TLR 57 mm Hg diastolic 57 acromegalic patients 57 trough FEV1 57 cTnI 57 min -1 57 mL/min/#.# m2 57 posttreatment 57 Viral load 57 liver histology 57 mIU ml 57 glycosylated hemoglobin levels 57 % CI #.#-#.# [001] 57 elevated transaminases 57 microg 57 triglyceride concentrations 57 serum CRP 57 Hypotension 57 test OGTT 57 isoprostane 57 8mg/kg 57 6mg 56 dehydroepiandrosterone sulfate 56 glyceryl 56 #.#/#.# mm Hg [003] 56 tipranavir r 56 corrected QT interval 56 pg ml 56 Alkaline Phosphatase 56 stimulated insulin secretion 56 Forced expiratory volume 56 ionized calcium 56 κ 56 nasal symptom 56 dyspnoea 56 International Normalized Ratio 56 Visual Analogue Scale VAS 56 serum concentrations 56 urinary N telopeptide 56 gadolinium enhancing 56 activated partial thromboplastin 56 confidence intervals CIs 56 lactulose 56 lymphocyte count 56 eosinophil count 56 XIENCE V PROMUS Stent 56 ischemia driven 56 glycated hemoglobin HbA1c 56 PaO 2 56 osmolality 56 MSLT 56 chloride secretion 56 corticosteroid dose 56 PASI scores 56 μg d 56 Hazard Ratio HR 56 cGy 56 splanchnic 56 #μg [002] 56 LDL triglycerides 56 postintervention 56 intraclass correlation coefficient 56 histological subtype 56 opacification 56 serum albumin 56 paricalcitol 56 cerebral oxygen saturation 56 detrusor overactivity 56 Aloxi injection 56 dose dependently 56 elevated ALT 56 bispectral index BIS 56 pulse amplitude 56 ug ml 56 Biochemical Oxygen Demand 56 serum homocysteine 56 baroreflex sensitivity 56 thyroglobulin 56 salmeterol fluticasone 56 androgen blockade 56 intraventricular 56 #.#mg l [001] 56 Fasting blood glucose 56 acetazolamide 56 #Gy 56 T2 lesion volume 56 left ventricular diastolic 56 primary patency 56 Diastolic 56 interobserver 56 -#.# ± [002] 56 hepatic enzyme 56 serum phosphorus 56 viral titers 56 dose atorvastatin 56 CK # plasma concentrations 56 artery stenosis 56 daily subcutaneous injections 56 iPTH 56 serum PTH 56 serum aminotransferase levels 56 #.#mL 56 isoenzyme 56 TPV r 56 hip BMD 56 atorvastatin #mg 56 postoperative morbidity 56 mcg QD 56 postprocedure 56 lumbar spine BMD 56 timolol 56 vasomotor 56 primary aldosteronism 56 Cypher Stent 56 #mg/m# [001] 56 biochemical relapse 56 lispro 56 ^ Tc 56 oral antidiabetic medication 56 systolic diastolic 56 hepatic enzymes 56 mol L 56 ejection fractions 56 fluticasone salmeterol 56 creatinine levels 56 scintigraphic 56 coronary stenosis 56 echocardiographic parameters 56 serum IgG 55 bivalirudin monotherapy 55 hyperintensity 55 diastolic pressures 55 endothelium dependent 55 deep venous thromboses 55 atazanavir ritonavir 55 fibrin deposition 55 pCR 55 QRS duration 55 fraction LVEF 55 metered dose inhaler MDI 55 hydroxy vitamin D 55 #.#-#.# [011] 55 #.#mg/kg [002] 55 QT QTc 55 TUNEL 55 Alanine 55 culture supernatants 55 injectable emulsion 55 HbA1C levels 55 ACTH 55 cecal intubation 55 μg L 55 apolipoprotein B 55 DLCO 55 systolic function 55 Troponin T 55 baroreceptor 55 inspiratory flow 55 sodium excretion 55 Kogenate ® FS 55 urine cytology 55 HER2 expression 55 Tasigna prolongs 55 BUPHENYL R sodium phenylbutyrate 55 confidence interval #.#-#.# 55 inhaled iloprost 55 intraabdominal 55 maximal aerobic capacity 55 unfractionated heparin UFH 55 g mL 55 mU L 55 arteriolar 55 Primary endpoints 55 μg ml 55 aminotransferases 55 pg mL 55 ± SEM 55 Lactate 55 transdermal estradiol 55 -#.# mg dL [002] 55 PSADT 55 inotropic agents 55 Apolipoprotein B 55 HBV DNA levels 55 p = .# [002] 55 Posaconazole 55 #.# MHz [002] 55 Plasma concentrations 55 perioperatively 55 elevated creatinine 55 plasma leptin 55 diastolic velocity 55 P ≤ 55 serum testosterone 55 Intraocular pressure 55 thyroid stimulating hormone TSH 55 Hemoccult II 55 demonstrated clinically meaningful 55 Demand BOD 55 serum triglycerides 55 P#Y# [002] 55 p = NS 55 Lipid Profile 55 serum potassium 55 peak plasma concentrations 55 manometry 55 pulmonary arterial 55 intratympanic 55 kg -1 55 fasting plasma glucose FPG 55 PCWP 55 interleukin IL -6 55 cefotaxime 55 hyperinsulinemic euglycemic clamp 55 controlled analgesia PCA 55 intracranial hemorrhage ICH 55 oocytes retrieved 55 Hcy 55 arterial oxygen saturation 55 ULORIC 55 Oswestry Disability Index 55 mg niacin 55 tolterodine ER 55 metabolite concentrations 55 incontinence episodes 55 biochemical recurrence 55 mmol 55 vertebrobasilar 55 preterm neonates 55 IPSS 55 plasma folate 55 mEq 55 GELNIQUE 55 lymphopenia 55 irbesartan 55 myocardial perfusion 55 chemoradiation therapy 55 ng dL 55 arterial elasticity 55 aminotransferase ALT 55 elevated LDH 55 mmHg systolic 55 anagrelide 55 ARB telmisartan 55 intraclass correlation coefficients 55 tPSA 55 decibel dB 55 Pred Forte 55 fluticasone propionate FP 55 progression TTP 55 Cardiorespiratory fitness 55 Myoglobin 55 achieved ACR# 55 peritoneal fluid 54 prolactin elevation 54 serum thyroglobulin 54 PANSS scores 54 Oral Glucose Tolerance 54 Ejection Fraction 54 AUCs 54 milliampere 54 ultrasonographic 54 AUC0 #hr 54 fasting plasma 54 thrombocytosis 54 mg/# [002] 54 interobserver agreement 54 epoetin alpha 54 myocardial contractility 54 lumbar spine bone 54 PEG IFN 54 glycated hemoglobin 54 estimated glomerular filtration 54 hemoglobin A1c HbA1c 54 1ppm 54 serum magnesium 54 nausea photophobia 54 Skin sterol 54 serum insulin 54 MMSE score 54 tirofiban 54 left ventricular systolic 54 IFN α 54 haematologic 54 oxycodone CR 54 micromolar 54 induration 54 hMG 54 plasma fibrinogen 54 ADCS ADL 54 β blockers 54 ACLR 54 mm Hg systolic 54 #.#mmol L [002] 54 μS cm 54 parenchymal 54 hyperphenylalaninemia HPA due 54 ALT normalization 54 H2RAs 54 mm3 54 EDARBI 54 tumor histology 54 ERalpha 54 prolonged QT interval 54 ALT elevation 54 telopeptide 54 postop 54 % CI #.#-#.# [007] 54 ADAS cog 54 elevated TSH 54 spectrophotometric 54 antigen PSA levels 54 transaminase levels 54 LDL HDL 54 sulcal 54 oral prednisolone 54 stent binary restenosis 54 μg dl 54 central corneal thickness 54 statin monotherapy 54 ug mL 54 seminal vesicle invasion 54 glycated hemoglobin levels 54 tricalcium phosphate 54 nmol liter 54 clinically meaningful improvement 54 transaminase 54 hypophosphatemia 54 LV dysfunction 54 3mg/kg 54 Prognostic significance 54 exhaled NO 54 hyperoxia 54 Chlamydia Rapid 54 intraobserver 54 dose Iluvien 54 plasma creatinine 54 cardiac perfusion 54 polysomnography PSG 54 GERD symptom 54 scfm 54 neurologic progression 54 serum triglyceride levels 54 myocardial oxygen 54 Total Harmonic Distortion 54 CCyR 54 aminotransferase 54 x ULN 54 mg QD 54 nerve conduction velocity 54 mg p = 54 #dhTxB# 54 #mg/day [001] 54 graft patency 54 p = #.# [003] 54 + PH# 54 CI #.#-#.# [001] 54 mmol kg 54 myocardial uptake 54 μg kg 54 obstructive CAD 54 overt nephropathy 54 gadolinium enhancing lesions 54 thrombus formation 54 0mg 54 budesonide formoterol 54 nonobstructive CAD 54 BENICAR HCT 54 W/cm2 54 gauge vitrectomy 54 virologic breakthrough 54 blood urea nitrogen 54 C telopeptide 54 ± #ppm [001] 54 diffusivity 54 deionised water 54 adenoma recurrence 54 T2 lesions 54 vasodilatation 54 Systolic 54 postoperative complication 54 TRUS 54 Cystatin C 54 adjunctive placebo 54 postoperative mortality 54 phonophobia 54 DAS# CRP 54 Pharmacokinetic parameters 54 #mm Hg 54 nasal airflow 54 ug kg 54 microbiological eradication 54 nondiabetic patients 54 serum creatinine levels 54 ADAS Cog 54 #.#mmHg 54 Main Outcome Measure 54 NYHA functional class 54 intracellular pH 54 fosamprenavir 54 serum urate levels 54 expiratory pressure 54 clinically meaningful reductions 54 steroidogenic 54 lowest tertile 54 sleep onset WASO 54 Hemodynamic 54 lopinavir r arm 53 variceal hemorrhage 53 1mg 2mg 53 salivary cortisol 53 HbA 1c 53 NDC #-#-# [001] 53 mg TID 53 mu g 53 Visual Analog 53 intravitreal injections 53 mcg mL 53 reintubation 53 serum phosphorous 53 #MHz bandwidth 53 serum calcium levels 53 CC genotype 53 HbA1C 53 urinary albumin excretion 53 serum IgE 53 urodynamic parameters 53 sodium potassium chloride 53 = #.#-#.# 53 #.#mg [003] 53 REYATAZ r arm 53 Adenomas 53 multivariable analysis 53 microalbumin 53 UPDRS Part III 53 MCF7 53 carotid artery intima media 53 esophageal acid 53 serum triglyceride 53 extrapyramidal symptoms 53 urinary albumin 53 Apidra ® 53 lumen diameter 53 plasma concentration Cmax 53 normothermic 53 GP IIb IIIa 53 Polyethylene Glycol 53 #HS [001] 53 fatigue asthenia 53 plasma pharmacokinetics 53 pulsatile flow 53 diastolic BP 53 atrial pacing 53 ERK activation 53 medroxyprogesterone acetate 53 umol L 53 esophagogastroduodenoscopy 53 hyperalgesia 53 Left Ventricular Ejection Fraction 53 Postoperative 53 postprandial glucose 53 angioplasty stenting 53 CIN3 + 53 mCi 53 Acetate Rectal Suppositories 53 prednisone prednisolone plus 53 urinary oxalate 53 bolus injection 53 atheroma volume 53 oligohydramnios 53 PSA kinetics 53 EBMT criteria 53 Index CDAI 53 blood lactate 53 enzyme inhibition 53 log# copies mL 53 chi squared 53 SpCO 53 reticulocytes 53 Febrile neutropenia 53 blood Phe 53 autoregulation 53 mg hydrochlorothiazide 53 distal anastomosis 53 carotid IMT 53 mU 53 Carotid 53 sUA 53 FEV1 forced expiratory 53 mg/# mL [002] 53 affective psychosis 53 #mg/kg [002] 53 serum HCV RNA 53 inflammatory biomarkers 53 Echocardiographic 53 human chorionic gonadotropin hCG 53 hepatic insulin sensitivity 53 indinavir 53 relapsed MM 53 transaminase elevations 53 #mg #mg #mg [003] 53 #.#mg/dL 53 Fasting plasma glucose 53 Crohn Disease Activity 53 cm sec 53 NIHSS 53 serum lipid levels 53 Scale PANSS 53 antibody titer 53 5mA 53 postprandial blood glucose 53 mild renal insufficiency 53 steroid dexamethasone 53 normoxic 53 #.#g/day 53 hemoglobin concentration 53 COHb 53 Platelet counts 53 resynchronization therapy 53 urate lowering therapy 53 urine excretion 53 micronuclei 53 1mg 53 μl 53 systolic dysfunction 53 mcg Albuferon 53 EQ 5D 53 Intrathecal 53 Mg Usa 53 deoxy 53 angiographic restenosis 53 μV 53 plasma homocysteine 53 linoleic acid LA 53 cerebral oxygenation 53 umbilical artery 53 extracapsular extension 53 dose clopidogrel 53 mm ³ 53 conjunctival hyperemia 53 clomipramine 53 mean corpuscular volume 53 epicardial 53 creatine phosphokinase 53 serum phosphate 53 Visual acuity 53 cobalamin 53 attain statistical significance 53 Holmium 53 ACE Inhibitor 53 sub maximal 53 receiving ISENTRESS 53 HBeAg negative patients 53 #.#cc [001] 53 triglycerides TG 53 cells μL 53 liver enzymes ALT 53 D Dimer 53 pulmonary exacerbations 53 axial length 53 #.#ml [002] 53 neointimal 53 HAQ DI 53 #dBc 53 interquartile range 53 postoperative hemorrhage 53 Ki# 53 #mg/dL [002] 53 Ankle Brachial Index 53 subcutaneous dose 53 IOP lowering 53 μL 53 lavage 53 3mg 53 milliliters mL 53 IIIa inhibitors 53 QTc prolongation 53 tryptase 53 peripheral insulin sensitivity 53 #.#mg 1mg 53 leucopenia 53 glucose concentrations 53 triglyceride TG 53 NIH CPSI 53 #ß 53 hetastarch 53 mg BID dose 53 ratio ICER 53 GI motility 53 mineral density BMD 53 equimolar 53 peri procedural 53 neutropaenia 53 Hb A1C 53 orthostatic 53 CD4 + cell 53 echogenicity 53 hours postdose 53 CorVue ™ 53 dalteparin 53 Elitek 53 μsec 53 cytogenetic response 53 biopsy Gleason 53 lupus anticoagulant 53 Urinalysis 53 piperacillin tazobactam 53 Hycamtin ® 53 HCV replicon 53 myocardial reperfusion 53 Error Vector Magnitude 53 Hazard Ratio = 53 prothrombin 53 micromoles 52 urinary excretion 52 tumor regressions 52 renal cysts 52 -#.# log# 52 ACh 52 mIU L 52 bezafibrate 52 blood oxygen saturation 52 #GS s 52 Insulin sensitivity 52 ertapenem 52 rizatriptan 52 prolactin levels 52 Î ¼ 52 D dimer 52 kidney ureter bladder 52 Fibromyalgia Impact Questionnaire 52 ‰ ¥ 52 ischemic lesions 52 sodium nitroprusside 52 Figure 1A 52 Tumor shrinkage 52 Mg Uk 52 zonisamide SR 52 platelet reactivity 52 CNS LS 52 L PPDS 52 flutamide 52 racemic albuterol 52 PREZISTA r arm 52 metabolic parameters 52 prospectively defined 52 #.#mg [001] 52 nodular partial response 52 #mg/mL 52 potassium supplementation 52 serum lipid 52 Pharmacodynamic 52 LDB CPR 52 sitosterol 52 saline placebo 52 mIU mL 52 tertiles 52 #mg dose [002] 52 oral levofloxacin 52 Stomatitis 52 QTc intervals 52 aminotransferase elevations greater 52 reduce serum phosphate 52 severe neutropenia 52 unresectable HCC 52 ejection fraction EF 52 BENICAR 52 -#.# mg dL [001] 52 specific alkaline phosphatase 52 octreotide LAR 52 echocardiographic 52 blood Phe levels 52 recombinant FSH 52 urinary sodium excretion 52 rosuvastatin #mg 52 ALT elevations 52 hematologic abnormalities 52 creatinine clearance 52 FOLFOX6 52 mEq L 52 GI toxicity 52 cough dyspnea 52 clinically meaningful improvements 52 semiquantitative 52 submaximal exercise 52 glutamate glutamine 52 Left Ventricular 52 χ 52 oxygen saturation SpO2 52 ug dose 52 crystalloid 52 % CI #.#-#.# [008] 52 millimoles 52 symptomatic VTE 52 posttransplant 52 urinary cadmium 52 ELISA assays 52 fibrinolysis 52 QTc interval 52 receiving prophylactic anticoagulation 52 mg Androxal 52 ULN 52 comparator arm 52 bronchoalveolar lavage fluid 52 daytime somnolence 52 injected subcutaneously 52 highest tertile 52 histrelin 52 bypass graft CABG surgery 52 lavage fluid 52 TPMT 52 HGPIN 52 Secondary endpoints 52 ml kg 52 vivo potency 52 postoperative chemotherapy 52 fluence 52 upper gastrointestinal bleeding 52 FEV1 52 BPH symptom 52 Stent thrombosis 52 CPAP adherence 52 GH deficiency 52 2mg 52 XIENCE V demonstrated 52 2dB 52 serum estradiol 52 prostatic fluid 52 pharmacokinetic PK profile 52 CK # plasma 52 Quantitation 52 eplerenone 52 periprocedural 52 Doppler sonography 52 antitrypsin 52 conduction velocity 52 intravaginal ejaculatory latency 52 plasminogen activator inhibitor 52 UPDRS motor 52 moderate renal impairment 52 QRS width 52 mcL 52 intima media thickness IMT 52 mitral annular 52 mean ± SEM 52 NovoLog ® Mix 52 CD4 CD8 52 plasma glucose 52 doxazosin 52 MADRS score 52 mcg kg min 52 bacteriuria 52 EBRT 52 erection hardness 52 CSBM 52 thickness IMT 52 lopinavir r 52 ventricular dilatation 52 occluded catheters 52 ADCS CGIC 52 distensibility 52 placebo PBO 52 Riboflavin 52 nitroprusside 52 pmol 52 achieved statistical significance 52 dexamethasone Decadron 52 Non inferiority 52 λ 52 mGy 52 LVEF 52 cTnT 52 Operative mortality 52 TNSS 52 subcutaneous infusion 52 prespecified secondary 52 #.#mg/kg [001] 52 spontaneous bowel movements 52 4mg 52 Pearson correlation coefficient 52 subscore 52 hematologic parameters 52 p# antigen 52 terfenadine 52 GORE TAG Device 52 maximal oxygen consumption 52 APACHE II 52 submaximal 52 invasive angiography 52 ANCOVA 52 immunochemical 52 ± #.#mm [001] 52 hyperintensities 52 mmHg p = 52 HIV RNA 52 LEXIVA r 52 plasma triglycerides 52 mcg ml 52 hepatic fat 52 myocardial viability 52 locoregional recurrence 52 intravenous dosing 52 IBDQ 52 cells mcL 52 #mg q8h